NCT00714519 is a Phase 2 clinical trial of Xenaderm® Ointment in Partial Thickness Wounds, sponsored by Healthpoint.

Who is sponsoring NCT00714519?

NCT00714519 is sponsored by Healthpoint.

What drugs are being tested in NCT00714519?

Interventions in NCT00714519: Xenaderm® Ointment, Placebo Comparator.

What condition does NCT00714519 study?

NCT00714519 studies Partial Thickness Wounds.

Is NCT00714519 still recruiting?

NCT00714519 is currently withdrawn. Last updated 29 August 2013.

Last reviewed 2013-08-29 · How we verify

NCT00714519

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Phase II Feasibility Study of Xenaderm® Ointment Exploring Design Issues for Phase III Efficacy in Partial-Thickness Wounds

Withdrawn Phase 2 Last updated 29 August 2013

What this trial tests

Phase 2 trial testing Xenaderm® Ointment in Partial Thickness Wounds. Withdrawn.

Timeline

1 July 2008

Primary endpoint
1 October 2008

1 October 2008

Quick facts

Lead sponsor	Healthpoint
Phase	Phase 2
Status	Withdrawn
Study type	INTERVENTIONAL
Allocation	randomized
Design	single group
Masking	triple
Primary purpose	treatment
Start date	1 July 2008
Primary completion	1 October 2008
Estimated completion	1 October 2008

Drugs / interventions tested

Xenaderm® Ointment
Placebo Comparator

Conditions studied

Partial Thickness Wounds — all drugs for Partial Thickness Wounds →

Sponsor

Healthpoint — full company profile →

Who can join

18 and older, any sex, with Partial Thickness Wounds. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Complete Wound Closure
Time frame: 21 days

Sponsor's own description

This study will assess if a clinical trial regarding healing of partial thickness wounds can be executed in nursing homes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT00714519 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Healthpoint
Last refreshed: 29 August 2013

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00714519.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing